-
2025-521712-19-00
5
2026-07-06
Colorectal Cancer
-
2025-520565-51-00
5
2026-06-23
small cell lung cancer
-
2025-523579-47-00
4
2026-06-19
moderate to severe rheumatoid arthritis (RA)
-
2025-522435-33-00
5
2026-06-17
Hemophilia A
-
2025-523576-23-00
5
2026-06-12
Unresectable Stage III non-small cell lung cancer without progression
-
2025-523586-18-00
5
2026-06-11
Non-Small Cell Lung Cancer
-
2025-523521-18-00
5
2026-06-09
Metastatic Colorectal Cancer
-
2025-522295-91-00
9
2026-06-05
relapsed or refractory Waldenstrom’s macroglobulinemia
-
2025-522697-37-00
7
2026-06-05
Amyotrophic Lateral Sclerosis
-
2025-524056-63-00
1
2026-06-05
microsatellite instability high/mismatch repair deficient (MSI-H/dMMR)
-
2025-523425-17-00
4
2026-06-03
Proteinuric kidney diseases
-
2025-521590-13-00
5
2026-05-28
Moderately to Severely Active Crohn’s Disease
-
2025-524060-38-00
3
2026-05-28
Active Ulcerative Colitis (UC)
-
2025-522001-38-00
4
2026-05-27
Crohn’s Disease
-
2025-523275-27-00
5
2026-05-26
X-Linked Protoporphyria (XLP)
-
2025-522511-42-00
4
2026-05-19
Crohn's disease
-
2025-522255-25-00
5
2026-05-18
Fallopian Tube Neoplasms
-
2025-524498-17-00
10
2026-05-08
Pretreated Unresectable Locally Advanced or Metastatic human epidermal
-
2024-514754-79-00
4
2026-05-06
Pulmonary Arterial Hypertension (PAH)
-
2023-508047-40-00
5
2026-04-30
Ovarian cancer
-
2024-511593-70-00
5
2026-04-27
Polyarticular-course juvenile idiopathic arthritis
-
2024-519830-22-00
5
2026-04-27
Heart failure due to systemic left ventricular systolic dysfunction
-
2024-517943-29-00
5
2026-04-21
Pulmonary Hypertension associated with interstitial lung disease (WHO
-
2024-519818-31-01
5
2026-04-10
Endometrial Cancer
Advanced, Recurrent, Metastatic, or Primary Unresec